Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Hair transplants can effectively treat hair loss from CCCA in African American women if there's no inflammation.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.